Is Waystar Capable of Competing with Increasing Rivals?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4d ago
0mins
Should l Buy WAY?
Source: Marketbeat
Company Overview: Waysstar Holding Corp. has established a strong reputation in the healthcare and cloud computing sectors, offering powerful software-as-a-service (SaaS) solutions that integrate payer networks with electronic health records.
Market Competition: The company faces increasing competition from similar firms like Phreesia Inc. and Doximity Inc., which may impact its market share, as Waysstar's shares have declined by 40% over the past year.
Financial Performance: Despite recent challenges, analysts predict growth across multiple metrics for Waysstar, including earnings and share price, with a reported net revenue retention of 113% for the latest quarter.
Acquisitions and Growth Strategy: Waysstar is expanding through acquisitions, including its recent purchase of Iodine Software, which is expected to enhance its market presence and revenue generation capabilities.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy WAY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on WAY
Wall Street analysts forecast WAY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for WAY is 47.81 USD with a low forecast of 40.00 USD and a high forecast of 54.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
17 Analyst Rating
16 Buy
1 Hold
0 Sell
Strong Buy
Current: 24.130
Low
40.00
Averages
47.81
High
54.00
Current: 24.130
Low
40.00
Averages
47.81
High
54.00
About WAY
Waystar Holding Corp. provides healthcare organizations with mission-critical cloud software that simplifies healthcare payments. The Company’s enterprise-grade platform, Waystar, streamlines the complex processes. It leverages internally developed artificial intelligence (AI) as well as proprietary, advanced algorithms to automate payment-related workflow tasks and drive continuous improvement, which enhances claim and billing accuracy, enriches data integrity, and reduces labor costs for providers. Its software is used daily by providers of all types and sizes across the continuum of care, including physician practices, clinics, surgical centers, and laboratories, as well as large hospitals and health systems. The Company’s clients utilize its software to manage pre-encounter workflows, such as eligibility checks and prior authorization approvals, as well as mid- and post-encounter workflows, such as co-pay collection, claims submission and monitoring, and payer remittances.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Is Waystar Capable of Competing with Increasing Rivals?
Company Overview: Waysstar Holding Corp. has established a strong reputation in the healthcare and cloud computing sectors, offering powerful software-as-a-service (SaaS) solutions that integrate payer networks with electronic health records.
Market Competition: The company faces increasing competition from similar firms like Phreesia Inc. and Doximity Inc., which may impact its market share, as Waysstar's shares have declined by 40% over the past year.
Financial Performance: Despite recent challenges, analysts predict growth across multiple metrics for Waysstar, including earnings and share price, with a reported net revenue retention of 113% for the latest quarter.
Acquisitions and Growth Strategy: Waysstar is expanding through acquisitions, including its recent purchase of Iodine Software, which is expected to enhance its market presence and revenue generation capabilities.
See More
Waystar Achieves Best in KLAS for Patient Access for Over a Decade
- Industry Recognition: Waystar has been named Best in KLAS for Patient Access, extending its streak of consecutive honors to over a decade, reflecting its outstanding performance in addressing healthcare financial challenges and solidifying its leadership in healthcare payment software.
- Financial Challenge Mitigation: Healthcare providers spend over $10 billion annually navigating complex payer authorization requirements, and Waystar's platform significantly reduces denial rates caused by front-end issues through real-time intelligence and autonomous workflows, enhancing client financial returns.
- Efficiency Gains: By integrating real-time visibility into insurance coverage with automated authorization, Waystar achieves a 55% reduction in eligibility-related denials and up to 90% auto-approval rates, thereby increasing provider revenue and improving patient access to care.
- Revenue Capture: Waystar aids providers in uncovering unknown insurance coverage before care begins, achieving a 55% discovery rate, and combined with pre-service estimation, accelerates collections and protects revenue, further enhancing patient satisfaction.
See More
Waystar Recognized as Best in KLAS for Patient Access
- Industry Recognition: Waystar has been awarded Best in KLAS® for Patient Access for over a decade, reflecting its outstanding performance in addressing financial challenges in healthcare payments and solidifying its leadership position in the industry.
- Financial Challenge Response: Healthcare providers spend over $10 billion annually navigating complex payer authorization requirements, and Waystar's AI platform significantly enhances revenue recovery efficiency, enabling providers to get paid faster and more accurately.
- Automation Authorization Benefits: By integrating real-time visibility into insurance coverage, Waystar achieves a 55% reduction in eligibility-related denials and up to 90% auto-approval rates, increasing provider revenue while improving the patient experience.
- Insurance Coverage Discovery: Waystar aids providers in uncovering unknown insurance coverage before care begins, achieving a 55% discovery rate, and combined with pre-service estimation, accelerates collections and protects revenue, further enhancing patient satisfaction.
See More
Waystar to Report Q4 and FY 2025 Financial Results on February 17, 2026
- Earnings Report Schedule: Waystar Holding Corp. will release its Q4 and FY 2025 financial results before market open on February 17, 2026, which is expected to positively impact investor confidence.
- Conference Call Details: The company will hold a conference call at 8:30 a.m. Eastern Time on the same day to provide real-time financial data analysis, enhancing transparency and attracting more investor interest.
- Webcast Availability: The conference call will be available via live audio webcast on Waystar's investor relations website, with an archived version for those unable to listen live, further improving information accessibility for investors.
- Client Base and Market Impact: Waystar serves over 30,000 clients, representing more than 1 million providers, processing over 7.5 billion healthcare payment transactions, showcasing its leadership and significant market influence in the healthcare payment sector.
See More
Waystar Introduces Agentic AI, Preventing $15.5 Billion in Denials
- AI Innovation: Waystar's introduction of Agentic AI workflows analyzes 30,000 data points, resulting in a 40% reduction in manual correction workload, enabling healthcare providers to process claims faster and enhance clinical work efficiency.
- Denial Prevention Impact: Over the past year, Waystar AltitudeAI has prevented $15.5 billion in denials, achieving 95% time savings for clients and double-digit increases in denial overturn rates, showcasing its significant influence in the healthcare payment sector.
- Addressing Nurse Shortages: The implementation of the new system not only alleviates administrative burdens but also helps relieve nurse burnout, particularly in light of the anticipated widespread nursing shortages by 2030, demonstrating Waystar's forward-thinking approach to industry challenges.
- Vision for Industry Transformation: Waystar's Agentic AI marks a crucial step towards an autonomous revenue cycle platform, leveraging a unique data network to simplify healthcare payments and empower providers to focus on patient care.
See More
Westwind Capital Fully Liquidates Waystar Position for $15.96 Million
- Liquidation Transaction: Westwind Capital disclosed in a recent SEC filing that it sold 420,897 shares of Waystar for an estimated $15.96 million, reducing its stake to zero and reflecting a cautious outlook on the company's future performance.
- Portfolio Reallocation: Waystar previously represented 3.3% of Westwind's assets under management, and following this liquidation, the fund's investments have shifted towards more liquid and stable giants like Visa and Amazon, indicating a strategy to avoid emerging platform risks.
- Performance Comparison: Despite Waystar achieving a 12% revenue growth in Q3, reaching $268.7 million, and management raising full-year guidance, Westwind's decision to liquidate suggests concerns over the disparity between Waystar's performance and broader market trends.
- Long-term Investment Strategy: This liquidation is viewed as a portfolio-level decision by Westwind Capital; while Waystar continues to scale profitably, its leverage and integration risks may test investor patience amid stock price volatility.
See More
Is Waystar Capable of Competing with Increasing Rivals?
Company Overview: Waysstar Holding Corp. has established a strong reputation in the healthcare and cloud computing sectors, offering powerful software-as-a-service (SaaS) solutions that integrate payer networks with electronic health records.
Market Competition: The company faces increasing competition from similar firms like Phreesia Inc. and Doximity Inc., which may impact its market share, as Waysstar's shares have declined by 40% over the past year.
Financial Performance: Despite recent challenges, analysts predict growth across multiple metrics for Waysstar, including earnings and share price, with a reported net revenue retention of 113% for the latest quarter.
Acquisitions and Growth Strategy: Waysstar is expanding through acquisitions, including its recent purchase of Iodine Software, which is expected to enhance its market presence and revenue generation capabilities.
See More
Waystar Achieves Best in KLAS for Patient Access for Over a Decade
- Industry Recognition: Waystar has been named Best in KLAS for Patient Access, extending its streak of consecutive honors to over a decade, reflecting its outstanding performance in addressing healthcare financial challenges and solidifying its leadership in healthcare payment software.
- Financial Challenge Mitigation: Healthcare providers spend over $10 billion annually navigating complex payer authorization requirements, and Waystar's platform significantly reduces denial rates caused by front-end issues through real-time intelligence and autonomous workflows, enhancing client financial returns.
- Efficiency Gains: By integrating real-time visibility into insurance coverage with automated authorization, Waystar achieves a 55% reduction in eligibility-related denials and up to 90% auto-approval rates, thereby increasing provider revenue and improving patient access to care.
- Revenue Capture: Waystar aids providers in uncovering unknown insurance coverage before care begins, achieving a 55% discovery rate, and combined with pre-service estimation, accelerates collections and protects revenue, further enhancing patient satisfaction.
See More
Waystar Recognized as Best in KLAS for Patient Access
- Industry Recognition: Waystar has been awarded Best in KLAS® for Patient Access for over a decade, reflecting its outstanding performance in addressing financial challenges in healthcare payments and solidifying its leadership position in the industry.
- Financial Challenge Response: Healthcare providers spend over $10 billion annually navigating complex payer authorization requirements, and Waystar's AI platform significantly enhances revenue recovery efficiency, enabling providers to get paid faster and more accurately.
- Automation Authorization Benefits: By integrating real-time visibility into insurance coverage, Waystar achieves a 55% reduction in eligibility-related denials and up to 90% auto-approval rates, increasing provider revenue while improving the patient experience.
- Insurance Coverage Discovery: Waystar aids providers in uncovering unknown insurance coverage before care begins, achieving a 55% discovery rate, and combined with pre-service estimation, accelerates collections and protects revenue, further enhancing patient satisfaction.
See More
Waystar to Report Q4 and FY 2025 Financial Results on February 17, 2026
- Earnings Report Schedule: Waystar Holding Corp. will release its Q4 and FY 2025 financial results before market open on February 17, 2026, which is expected to positively impact investor confidence.
- Conference Call Details: The company will hold a conference call at 8:30 a.m. Eastern Time on the same day to provide real-time financial data analysis, enhancing transparency and attracting more investor interest.
- Webcast Availability: The conference call will be available via live audio webcast on Waystar's investor relations website, with an archived version for those unable to listen live, further improving information accessibility for investors.
- Client Base and Market Impact: Waystar serves over 30,000 clients, representing more than 1 million providers, processing over 7.5 billion healthcare payment transactions, showcasing its leadership and significant market influence in the healthcare payment sector.
See More
Waystar Introduces Agentic AI, Preventing $15.5 Billion in Denials
- AI Innovation: Waystar's introduction of Agentic AI workflows analyzes 30,000 data points, resulting in a 40% reduction in manual correction workload, enabling healthcare providers to process claims faster and enhance clinical work efficiency.
- Denial Prevention Impact: Over the past year, Waystar AltitudeAI has prevented $15.5 billion in denials, achieving 95% time savings for clients and double-digit increases in denial overturn rates, showcasing its significant influence in the healthcare payment sector.
- Addressing Nurse Shortages: The implementation of the new system not only alleviates administrative burdens but also helps relieve nurse burnout, particularly in light of the anticipated widespread nursing shortages by 2030, demonstrating Waystar's forward-thinking approach to industry challenges.
- Vision for Industry Transformation: Waystar's Agentic AI marks a crucial step towards an autonomous revenue cycle platform, leveraging a unique data network to simplify healthcare payments and empower providers to focus on patient care.
See More
Westwind Capital Fully Liquidates Waystar Position for $15.96 Million
- Liquidation Transaction: Westwind Capital disclosed in a recent SEC filing that it sold 420,897 shares of Waystar for an estimated $15.96 million, reducing its stake to zero and reflecting a cautious outlook on the company's future performance.
- Portfolio Reallocation: Waystar previously represented 3.3% of Westwind's assets under management, and following this liquidation, the fund's investments have shifted towards more liquid and stable giants like Visa and Amazon, indicating a strategy to avoid emerging platform risks.
- Performance Comparison: Despite Waystar achieving a 12% revenue growth in Q3, reaching $268.7 million, and management raising full-year guidance, Westwind's decision to liquidate suggests concerns over the disparity between Waystar's performance and broader market trends.
- Long-term Investment Strategy: This liquidation is viewed as a portfolio-level decision by Westwind Capital; while Waystar continues to scale profitably, its leverage and integration risks may test investor patience amid stock price volatility.
See More
